Please try another search
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical company. The Company operates five segments. The Biopharmaceutical segment is engaged in research, development, production and sales of biological products, and its primary product is mouse nerve growth factor for injection named Jinlujie. The Medical Technology Service segment is mainly involved in the technical development, technical consultation and technology transfer of chemical drugs. The In Vitro Diagnostic Reagents segment operates the research, development, production and sales of in vitro diagnostic reagents. The Pharmaceutical Sales and Wholesale segment is engaged in the sales and wholesale of pharmaceuticals. The Other segment’s businesses include the cultivation and sales of Chinese herbal medicines, and the wholesale and retail of health products.
Name | Age | Since | Title |
---|---|---|---|
Han Zhen Xia | 58 | - | CFO & Director |
Huang Chen | 46 | 2012 | Deputy GM, Secretary & Director |
Jie Zhang | 52 | - | Chairman of the Supervisory Board |
Ya Chen | 49 | - | Chairman of the Board & GM |
Hua Dong Tang | 43 | - | Member of the Supervisory Board |
Jia Feng Zhu | 52 | - | Director |
Jie Yan | - | - | Director |
Tao Wang | - | 2021 | Independent Director |
Mingdong Ran | - | 2021 | Independent Director |
Tao Yang | - | 2021 | Non-Independent Director |
Wenxin Li | - | 2021 | Independent Director |
Jing Du | 39 | 2018 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review